Antinuclear antibodies in childhood immune thrombocytopaenia: An increased risk for development of autoimmune disorders?

Antinuclear antibodies (ANA) have been detected in children with primary immune thrombocytopaenia (ITP), but the effect of ANA titres on clinical outcomes is unclear. Liu et al. retrospectively analysed a cohort of 324 children with primary ITP with a median follow-up time of 25 months and found that patients with high-ANA titres (≥1:160) had lower platelet counts at the onset with a higher subsequent platelet count recovery rate, and additionally were at an increased risk to develop autoimmune disease. These data highlight the possible predictive potential of ANA titres with respect to platelet counts and the development of autoimmunity in children with primary ITP. Commentary on: Liu, et al. The effect of antinuclear antibody titre and its variation on outcomes in children with primary immune thrombocytopaenia. Br J Haematol 2023;202:412-421.
AuthorsRick Kapur
JournalBritish journal of haematology (Br J Haematol) Vol. 202 Issue 2 Pg. 215-216 (07 2023) ISSN: 1365-2141 [Electronic] England
PMID37006171 (Publication Type: Journal Article, Comment)
Copyright© 2023 British Society for Haematology and John Wiley & Sons Ltd.
Chemical References
  • Antibodies, Antinuclear
  • Child
  • Humans
  • Antibodies, Antinuclear (analysis)
  • Purpura, Thrombocytopenic, Idiopathic
  • Retrospective Studies
  • Autoimmune Diseases
  • Thrombocytopenia
  • Platelet Count

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!

Choose Username:
Verify Password:
Enter Code Shown: